Latest News

George Clinical announces the appointment of James Cheong to the role of Chief Operating Officer

SYDNEY, January 22, 2019 – George Clinical, headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief Operating Officer. With extensive management experience spanning over two decades, Cheong brings valuable leadership to George Clinical’s executive team during a period of strong expansion and growth. […]

Read More

January 22nd, 2019

Taiwan’s Pragmatic Timelines Make it a ‘Top-Tier’ Country for MRCTs

George Clinical welcomes The Taiwan Food and Drug Administration’s (TFDA) recent clarified timelines for approval of a general Clinical Trial Authority (CTA) at 45 calendar days. The announcement, released by the TFDA in October, adds to the suite of attractive options to expedite clinical trial regulatory approval timelines in Taiwan. This includes the existing 15 […]

Read More

January 8th, 2019

Established Investigator Networks Are Central to the Strength of the Clinical Trial Environment

The importance of securing strong, long-standing investigator networks with leading research hospitals and clinics is critical to the continued growth of the clinical trial environment in countries such as Taiwan, says Evon Hui, Head of Business Operations, East Asia. Over the past 15 years, George Clinical has cultivated an enviable network of MOUs that have […]

Read More

January 6th, 2019

George Clinical Recognized with Employer Award by Hong Kong Authority

George Clinical, a leading clinical research organization (CRO) in the Asia-Pacific region, has gained recognition of the organization’s strong support of the Mandatory Provident Fund (MPF) legislation, and their provision of good MPF benefits. The Mandatory Provident Fund Schemes Authority (MPFA) awarded George Clinical their Good MPF Employer Award at a ceremony in Hong Kong […]

Read More

January 5th, 2019

George Clinical Scientific Leader Jason Chandler Sees Approval of New Therapy

George Clinical welcomes the decision by the FDA to approve the delivery of CAR-T therapy in a partnership between Methodist Healthcare, and George Clinical Scientific Leader, Dr. Jason Chandler of West Cancer Center. Car-T therapies are at the cutting edge of treatment for a range of cancers. The recent announcement by the FDA, West Cancer […]

Read More

January 4th, 2019

Heart Health Research Center provides extensive research training and investigator networks to leading CRO George Clinical

Beijing, November 13, 2018 – George Clinical, a leading clinical research organization (CRO) in the Asia-Pacific region, has continued its involvement and collaboration with the Heart Health Research Center (HHRC), further developing the depth and quality of investigator networks. The HHRC, a collaborative initiative developed by Cardio Union, an emerging multi-disciplinary healthcare organization and the […]

Read More

December 6th, 2018

60 Day Window for Clinical Trial Approval Official, says George Clinical, a leading Asia-Pacific CRO.

9 AUGUST, 2018 – (BEIJING) In another positive development in China’s rapidly evolving regulatory environment The China National Drug Administration (CNDA) has introduced a 60-day window for clinical trial approvals, mirroring US FDA protocols. The rules have taken immediate effect. “This new ruling has major implications for sponsors wishing to conduct China-only or multi-centre studies […]

Read More

August 15th, 2018
Changes in china

There has never been a better time to consider China as part of your development strategy!

In another encouraging step towards making China a leading destination for clinical drug trials, some critical developments were announced at The Executive Meeting of the State Council on the 12th April 2018. From 1 May 2018, the import tariff of all common drugs including anticancer drugs, alkaloids with anticancer effects and the imported Chinese patent […]

Read More

April 19th, 2018
Utilizing clinical research organization for late phase I studies

George Clinical Promotes Matthew Reabold, Sr., to Head of Business Development, USA

George Clinical, a leading full-service CRO in the US and Asia-Pacific region, is pleased to announce that Matthew Reabold, Sr. has been promoted to the Head of Business Development, USA. George Clinical, headquartered in Sydney, Australia, operates in fifteen countries around the world and has major operational hubs in the USA, East Asia, China, and India. Matthew, who is USA based, will […]

Read More

December 13th, 2017
China

Significant changes ahead for drug development in China?

Significant changes are ahead for clinical research in China. The Public Consultation Notice for Policies to Encourage Innovation and Reform in Regulation of Drug and Medical Device Clinical Testing was released by the CFDA on 11 May, 2017. These proposed changes herald an exciting new era for drug and device development. If implemented in full, […]

Read More

June 16th, 2017

Join our Mailing List


Add George Clinical to your network